BRIEF-Allergan And Richter Announce Positive Topline Results From Phase 3 Study Of Cariprazine For Treatment Of Bipolar I Depression

* ALLERGAN AND RICHTER ANNOUNCE POSITIVE TOPLINE RESULTS FROM PHASE 3 STUDY OF CARIPRAZINE FOR THE TREATMENT OF BIPOLAR I DEPRESSION
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.